Global Transdermal Drug Delivery Systems Market Research Report

Report Highlights

The scope of this report is broad and covers different types of transdermal drug delivery systems markets, along with the different applications and major countries. The market is broken down by form, application, technology type, and regional markets. Revenue forecasts from 2019 to 2026 are given for each major type of transdermal drug delivery system market, segment, and regional market, and the estimated values are derived from the manufacturers' total revenues.

The report also includes a discussion of the major players across each regional transdermal drug delivery systems market; it explains the major market drivers of the global transdermal drug delivery systems market industry, current trends within the industry, major architectures, and the regional dynamics of the global transdermal drug delivery systems market.
The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global transdermal drug delivery systems market.

Summary.

There are several methods or processes of administering an active pharmaceutical ingredient (drug substance) to achieve a therapeutic effect in humans. Topical and transdermal drug delivery are the common methods. Even though topical and transdermal medications/ formulations are typically applied to the skin and present similar manufacturing and quality control concerns and risks to patients; they are substantially different in their mechanism of action. Transdermal drug delivery systems (TDDS) deliver an active pharmaceutical ingredient (API) across the skin and systemic circulation, while topical drug delivery systems are designed to deliver the active ingredient to local tissue.

The market is segmented into passive and active transdermal drug delivery systems based on technology. Passive transdermal drug delivery system holds the largest market share in the global technology segment of transdermal drug delivery systems.